Trump Declares Intent To Stop Pharma Companies From ‘Gaming’ Patent System 11/05/2018 by William New, Intellectual Property Watch 2 Comments US President Trump today declared in a White House speech his intent to “take steps” to lower drug prices by stopping “gaming of regulatory and patent processes by drug makers to unfairly protect monopolies,” as well as increasing price transparency and promoting biosimilars and generics. But to do this, his administration will take on what it sees as “freeloading” on US innovation by foreign governments, and addressing “unfair” intellectual property and market access policies in trade agreements.
Truvada Case Shows Civil Society’s Success With Pre-Grant Opposition 08/05/2018 by Catherine Saez, Intellectual Property Watch 15 Comments The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to patents it felt were unjustified were rewarded by patent withdrawal and rejection, even if the situation in Brazil might not be entirely settled.
Civil Society Key In TRIPS Flexibility Implementation 04/05/2018 by Catherine Saez, Intellectual Property Watch 22 Comments When the agreement on intellectual property was adopted by the World Trade Organization, a number of flexibilities were included in the text, mainly to give developing countries policy space to implement the agreement with development considerations. However, some countries through lack of awareness or economic pressure have not used those flexibilities fully, and found themselves facing difficulties addressing their public health needs, which some associate with this failure to use the flexibilities. Civil society has engaged in notable efforts to counter pressure and raise policymakers’ awareness for a wider access to medicines.
World Health Assembly 2018 Preview: Guide To Key Issues 03/05/2018 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization celebrated its 70th anniversary last month. Since the inception of the organisation, the world has changed, and so have its challenges. The global rise of non-communicable diseases is one example of those challenges, as well as the escalating prices of new medicines and chronic access issues in many countries. The annual World Health Assembly will open on 21 May with an ambitious new General Programme of Work for 2019-2023, which promises 1 billion more people under universal health coverage.
Ukraine Eyes Patent Law Reform After Civil Society Push On Medicines Access 30/04/2018 by Dugie Standeford for Intellectual Property Watch 14 Comments Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups for better access to affordable medicines and healthcare.
USTR IP Report Sparks Outcry Among Health Advocates 27/04/2018 by William New, Intellectual Property Watch 4 Comments The annual Special 301 report of the Office of the United States Trade Representative (USTR) issued today sparked a quick outcry among health advocates over its seemingly more restrictive approach they say bullies other countries into unfairly promoting US pharmaceutical industry rights to an extent that would raise drug prices and limit accessibility.
EU Commission Outlines Approach On Artificial Intelligence 25/04/2018 by William New, Intellectual Property Watch Leave a Comment The European Commission today issued an outline of a European approach on artificial intelligence to “boost investment and set ethical guidelines.” The aim is to have a coordinated plan with member states by year’s end.
Interpol Highlights Takedown Of Deadly Global Fake Food And Drink Operations 25/04/2018 by Intellectual Property Watch 1 Comment Weevil-infested flour, deadly methanol added to alcohol, borax to make products seem fresher, pesticide-laced shrimp, fake medicines. Global police organisation Interpol today detailed a multi-agency operation that dismantled nearly 50 criminal networks worldwide that provided fake and substandard food and drink that put people in danger and killed dozens.
Dozens Of NGOs Oppose Proposed EU Watch List On IP Rights 16/04/2018 by William New, Intellectual Property Watch Leave a Comment A wide-ranging list of international nongovernmental organisations today issued a letter to European Trade Commissioner Cecilia Malmström opposing a proposal to establish a “watch list” of countries deemed failing to protect European intellectual property. The groups raised concern that the list would violate World Trade Organization rules on intellectual property, have a chilling effect on developing countries’ public health initiatives, and lead to expanded and untenable levels of IP enforcement.
Fairness In Research Partnerships, Reporting System Presented At Geneva Health Forum 13/04/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Research collaborations between institutions in the North and institutions in the South often show a scientific and power imbalance. In the context of growing concerns about this issue, initiatives are being developed to increase fairness in research partnerships. In particular, the Research Fairness Initiative, providing a reporting system for institutions is gaining traction, according to speakers at the Geneva Health Forum this week.